title: [Bacterial multiresistance emergence in South-Western Romania].
abstract: BACKGROUND
  European Centre for Diseases Control (ECDC), involved in the surveillance of nosocomial infections (NI) and resistance to antimicrobials (AMR) in Europe, estimates 4 million IN/year, among whom 37,000 deceased, out of which half are determined by multiresistant germs (MDR). A phenomenon encountered more and more often is that of pan-resistance of germs, without the option for an optimal antibiotherapy. The allarming increase of AMR is a phenomenon which our country also faces in the present.
  Resistance rate registered in Intensive Care Units in Timişoara during 2005-2007 (when we participated in the Helics European network) situates us among the last places among the European countries that participated--with 50-60% MRSA strains, 24% E. coli BLSE strains, 62,7% K. pneumoniae BLSE strains, 34% P. aeruginosa BLSE. Furthermore, data registered in ambulatory in the South-West part of Romania during 2006-2007 (processed by the greatest private laboratory in the region) are not more optimistic--26% MRSA strains, 4,25% E. coli BLSE, 12,49% K. pneumoniae BLSE, 8,69% P. aeruginosa BLSE.
  
  
  CONCLUSIONS
  As the management of MDR produced infections requires huge costs, a better antibiotic policy in the Romanian hospitals and ambulatory is compulsive, being more efficient to spend for control than for the treatment of these infections.
authors.affiliation: Universitatea de Medicină şi Farmacie "Victor Babeş" Timişoara.
authors.forename: Monica
authors.initials: M
authors.lastname: Licker
authors.forename: Luminiţa
authors.initials: L
authors.lastname: Bădiţoiu
authors.forename: C
authors.initials: C
authors.lastname: Negru
authors.forename: Cristina
authors.initials: C
authors.lastname: Brînzeu
authors.forename: Roxana
authors.initials: R
authors.lastname: Zugravu
authors.forename: F
authors.initials: F
authors.lastname: Horhat
authors.forename: Roxana
authors.initials: R
authors.lastname: Moldovan
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000187:drug effects*; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D011159:Population Surveillance; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012383:Romania / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents